Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection
about
Different serological cross-reactivity of Trypanosoma rangeli forms in Trypanosoma cruzi-infected patients seraImmunotherapy of Trypanosoma cruzi infection with DNA vaccines in miceImmunization with cDNA expressed by amastigotes of Trypanosoma cruzi elicits protective immune response against experimental infectionProphylactic efficacy of TcVac2 against Trypanosoma cruzi in mice.DNA immunization with Na+-K+ ATPase (Sseat-6) induces protective immunity to larval Strongyloides stercoralis in miceCo-administration of a plasmid DNA encoding IL-15 improves long-term protection of a genetic vaccine against Trypanosoma cruziCD8(+) T cell-mediated immunity during Trypanosoma cruzi infection: a path for vaccine development?Testing the efficacy of a multi-component DNA-prime/DNA-boost vaccine against Trypanosoma cruzi infection in dogs.CD8+-T-cell-dependent control of Trypanosoma cruzi infection in a highly susceptible mouse strain after immunization with recombinant proteins based on amastigote surface protein 2.Recombinant yellow fever viruses elicit CD8+ T cell responses and protective immunity against Trypanosoma cruziVaccination using recombinants influenza and adenoviruses encoding amastigote surface protein-2 are highly effective on protection against Trypanosoma cruzi infectionBiological and immunological characterization of recombinant Yellow Fever 17D viruses expressing a Trypanosoma cruzi Amastigote Surface Protein-2 CD8+ T cell epitope at two distinct regions of the genomeA human type 5 adenovirus-based Trypanosoma cruzi therapeutic vaccine re-programs immune response and reverses chronic cardiomyopathy.Humoral and cellular immune responses to Trypanosoma cruzi-derived paraflagellar rod proteins in patients with Chagas' disease.Anatomical route of invasion and protective mucosal immunity in Trypanosoma cruzi conjunctival infection.Antigen targeting to dendritic cells allows the identification of a CD4 T-cell epitope within an immunodominant Trypanosoma cruzi antigenECG detection of murine chagasic cardiomyopathy.A DNA vaccine encoding for TcSSP4 induces protection against acute and chronic infection in experimental Chagas diseasePhenyl-alpha-tert-butyl nitrone reverses mitochondrial decay in acute Chagas' disease.A Two-Component DNA-Prime/Protein-Boost Vaccination Strategy for Eliciting Long-Term, Protective T Cell Immunity against Trypanosoma cruziDifferential phenotypic and functional profiles of TcCA-2 -specific cytotoxic CD8+ T cells in the asymptomatic versus cardiac phase in Chagasic patients.The Immune Response to Trypanosoma cruzi: Role of Toll-Like Receptors and Perspectives for Vaccine Development.Generation, specificity, and function of CD8+ T cells in Trypanosoma cruzi infection.Innate and acquired immunity in the pathogenesis of Chagas disease.Parasite-induced chronic inflammation is not exacerbated by immunotherapy before or during Trypanosoma cruzi Infection.DNA vaccines against tropical parasitic diseases.An overview of chagasic cardiomyopathy: pathogenic importance of oxidative stress.Current status and future prospects for a vaccine against American trypanosomiasis.Methodological approach to the ex vivo expansion and detection of T. cruzi-specific T cells from chronic Chagas disease patients.Oral vaccination with Salmonella enterica as a cruzipain-DNA delivery system confers protective immunity against Trypanosoma cruzi.Developments in the management of Chagas cardiomyopathy.Previously unrecognized vaccine candidates control Trypanosoma cruzi infection and immunopathology in miceNovel protective antigens expressed by Trypanosoma cruzi amastigotes provide immunity to mice highly susceptible to Chagas' disease.DNA Vaccines against Protozoan Parasites: Advances and ChallengesLong-Term Immunity to Trypanosoma cruzi in the Absence of Immunodominant trans-Sialidase-Specific CD8+ T Cells.Effect of the plasmid-DNA vaccination on macroscopic and microscopic damage caused by the experimental chronic Trypanosoma cruzi infection in the canine model.Accelerating the development of a therapeutic vaccine for human Chagas disease: rationale and prospectsChagas' disease: an update on immune mechanisms and therapeutic strategiesPerforin and gamma interferon expression are required for CD4+ and CD8+ T-cell-dependent protective immunity against a human parasite, Trypanosoma cruzi, elicited by heterologous plasmid DNA prime-recombinant adenovirus 5 boost vaccination.Utility of the Trypanosoma cruzi sequence database for identification of potential vaccine candidates by in silico and in vitro screening.
P2860
Q21198946-00ED57F7-6133-4112-8348-EE89948A2703Q24602785-EEF70320-96E8-4D4D-858C-DABFB481DCBBQ30452989-F62F9B01-1D66-4021-8C89-568A27A63F06Q33656471-80E715A3-3EB4-41AC-B854-D3038E1E5770Q33769376-92F27CBB-ADA4-404D-AFB8-8684326EC508Q33847435-F54CA1EA-A405-459E-82E4-26FAB8A45050Q33914939-D0EA245C-A633-44C2-9BAC-88A307ECD808Q33916310-300A9734-FAD1-47F1-8002-78DA2C523611Q34034104-011AAA39-AE3D-4C8A-8ECB-D53C050E8ACEQ34635043-E5C4C6B0-BEC0-4871-AA59-602D48C38189Q34700649-022F343B-3D08-43BB-A3EA-BC3DC9C2BB29Q34732681-DDB34C92-F009-4198-9D2C-61C169699B2CQ35009081-84A9BF14-977F-4663-A4A7-B4B1B2280807Q35011455-9EADBDCF-D705-45E4-B876-E64E5D1B2E33Q35073839-E12E98E0-554E-43E7-8207-4BFE74877166Q35095495-27FD8171-01D7-4F7E-96F2-A992153E7C03Q35148047-A4D90402-EE4C-4698-8E05-1CB0B1536C58Q35565140-2EB5234B-7165-48A5-A9CD-07504A1A51A7Q35569849-D7548324-180B-4721-B024-7AC0B180C162Q35581314-6C3453F5-2490-4117-B1A3-8DCA7A06787FQ35588670-C73BC0EE-B052-42AE-B5CE-90BCC0FB3AECQ35838023-F18F0111-B06D-4E4C-B3DB-10849F39D4F1Q35884259-B47F5DB0-CC25-48ED-8B68-3DF2FDA882EEQ35994773-74E2A90D-14ED-4DCF-97AB-00A955ABB343Q36097139-0A2D4785-46DE-4B22-B767-23756E7F5215Q36238733-0B993526-C8D8-4D76-B9BA-937A9E21FF0BQ36338129-1A1509AA-03C5-4D5F-AACF-8709DF507FC4Q36350576-324994C0-0484-48B7-A136-0A92F44D8A9CQ36383902-3FF8B9C7-BF52-4BCB-B714-69133611C550Q36422127-CCEEC6F9-DBB1-450E-A1BA-12E341C25808Q36737035-2DE47596-014A-4174-9DF0-A10B3265AC52Q36844866-BF30B47C-D398-4120-A7F2-C16CAB98795AQ36844914-3C17F7B4-96B5-4FD7-BCDE-34A57D2B3868Q36915067-E7ADFF2C-34FF-4F5F-9F9E-93CC86D8A0AAQ37199864-BC323751-80ED-4075-8F0E-BFF22391973AQ37217917-2240CF56-7C61-4FDF-AD6E-E6BFE8E3B54AQ37286061-34763301-683C-4658-B1CB-A62C8360B6ABQ37310959-306080A1-DC87-4212-951C-5532C1BABC86Q37355936-DD8AECB6-3643-433D-A913-185DEA6064BCQ37582887-A40FC1AA-370A-4BD6-88CD-0C7C3A4AA888
P2860
Genetic immunization elicits antigen-specific protective immune responses and decreases disease severity in Trypanosoma cruzi infection
description
2002 nî lūn-bûn
@nan
2002 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2002 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
name
Genetic immunization elicits a ...... in Trypanosoma cruzi infection
@ast
Genetic immunization elicits a ...... in Trypanosoma cruzi infection
@en
Genetic immunization elicits a ...... in Trypanosoma cruzi infection
@nl
type
label
Genetic immunization elicits a ...... in Trypanosoma cruzi infection
@ast
Genetic immunization elicits a ...... in Trypanosoma cruzi infection
@en
Genetic immunization elicits a ...... in Trypanosoma cruzi infection
@nl
prefLabel
Genetic immunization elicits a ...... in Trypanosoma cruzi infection
@ast
Genetic immunization elicits a ...... in Trypanosoma cruzi infection
@en
Genetic immunization elicits a ...... in Trypanosoma cruzi infection
@nl
P2860
P1476
Genetic immunization elicits a ...... in Trypanosoma cruzi infection
@en
P2093
Nisha Garg
P2860
P304
P356
10.1128/IAI.70.10.5547-5555.2002
P407
P577
2002-10-01T00:00:00Z